{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T11:10:20Z","timestamp":1735470620808,"version":"3.32.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1993,11,1]],"date-time":"1993-11-01T00:00:00Z","timestamp":752112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[1993,11]]},"DOI":"10.1007\/bf01351832","type":"journal-article","created":{"date-parts":[[2005,3,27]],"date-time":"2005-03-27T11:00:39Z","timestamp":1111921239000},"page":"301-303","source":"Crossref","is-referenced-by-count":0,"title":["Decrease of serum calcium concentration and lost influence of calcium on parathyroid hormone release in a patient with primary hyperparathyroidism after treatment with diphosphonates"],"prefix":"10.1007","volume":"53","author":[{"given":"Harold","family":"Kotzmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bernecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Svoboda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Niederle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Luger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"903","volume":"102","author":"B Niederle","year":"1987","unstructured":"Niederle B, Roka R, Woloszczuk W, Klaushofer K, Kovarik J, Schernthaner G (1987) Successful parathyroidectomy in primary hyperparathyroidism: a clinical follow-up study of 212 consecutive patients. Surgery 102:903?909","journal-title":"Surgery"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","volume":"302","author":"HW Heath III","year":"1980","unstructured":"Heath HW III, Hodgson SF, Kennedy MA (1980) Primary hyperparathyroidism: incidence, morbidity and potential economic impact on the community. N Engl J Med 302:189?193","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199204303261806","volume":"326","author":"JP Bilezikian","year":"1992","unstructured":"Bilezikian JP (1992) Management of acute hypercalcaemia. N Engl J Med 326:1196?1203","journal-title":"N Engl J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/jbmr.5650020506","volume":"2","author":"S Adami","year":"1987","unstructured":"Adami S, Bolzicco GP, Rizzo A, Salvagno G, Bertoldo F, Rossini M, Suppi R, LoCascio V (1987) The use of dichloromethylene biphosphonate and aminobutane biphosphonate in hypercalcemia of malignancy. J Bone Miner Res 2:395?404","journal-title":"J Bone Miner Res"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/bjc.1987.225","volume":"56","author":"RE Coleman","year":"1987","unstructured":"Coleman RE, Rubens RD (1987) 3(amino-1.1-hydroxypro-pylidene) biphosphonate (APD) for hypercalcaemia of breast cancer. Br J Cancer 56:465?469","journal-title":"Br J Cancer"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0140-6736(89)91791-1","volume":"ii","author":"SH Ralston","year":"1989","unstructured":"Ralston SH, Gallacher SJ, Patel U, Dryburgh FJ, Fraser WD, Cowan RA, Boyle IT (1989) Comparison of three intravenous biphosphonates in cancer-associated hypercalcaemia. Lancet ii:1180?1182","journal-title":"Lancet"},{"key":"CR7","first-page":"52","volume-title":"The management of bone metastases and hypercalcaemia by osteoclast inhibition","author":"RE Coleman","year":"1990","unstructured":"Coleman RE (1990) Pamidronate (APD) treatment of bone metastases from breast cancer. In: Rubens RD (ed) The management of bone metastases and hypercalcaemia by osteoclast inhibition. Hogrefe and Huber, Toronto\/Lewiston NY\/Bern\/ G\u00f6ttingen\/Stuttgart, pp 52?61"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(79)91319-9","volume":"ii","author":"FJM Breukelen Van","year":"1979","unstructured":"Van Breukelen FJM, Bijvoet OLM, Van Oosterom AT (1979) Inhibition of osteolytic bone lesions by 3-amino-1-hydroxypropylidene-1,1-biphosphonate (APD). Lancet ii:803?805","journal-title":"Lancet"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.1780231017","volume":"23","author":"D Douglas","year":"1980","unstructured":"Douglas D, Duckworth T, Kanis JA (1980) Biochemical and clinical responses to dichloromethylene diphosphonate (C12MDP) in Paget's disease of bone. Arthritis Rheum 23:1185?1192","journal-title":"Arthritis Rheum"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0002-9343(88)80344-9","volume":"85","author":"D Thiebaud","year":"1988","unstructured":"Thiebaud D, Jaeger P, Gobelet CH, Jacquet F, Burckardt P (1988) A single infusion of biphosphonate AHPrBP (APD) as treatment of Paget's disease of bone. Am J Med 85:207?212","journal-title":"Am J Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2265.1990.tb00504.x","volume":"33","author":"S Adami","year":"1990","unstructured":"Adami S, Mian M, Bertoldo F, Rossini M, Jayawerra P, O'Riordan JLH, Lo Cascio V (1990) Regulation of calciumparathyroid hormone feedback in primary hyperparathyroidism: effects of biphosphonate treatment. Clin Endocrinol 33:391?397","journal-title":"Clin Endocrinol"},{"issue":"suppl 1","key":"CR12","first-page":"69","volume":"8","author":"NA Hamdy","year":"1987","unstructured":"Hamdy NA, Gray RE, Closkey MC, Rattenbury JM, Brown CB, Kanis JA (1987) Clodronate in the medical management of hyperparathyroidism. Bone 8(suppl 1):69?77","journal-title":"Bone"},{"key":"CR13","first-page":"480","volume":"110","author":"S Jansson","year":"1991","unstructured":"Jansson S, Tisell LE, Lindstedt G, Lundberg PA (1991) Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism. Surgery 110:480?486","journal-title":"Surgery"},{"key":"CR14","first-page":"441","volume-title":"Handbook of experimental pharmacology, vol. 83","author":"H Fleisch","year":"1988","unstructured":"Fleisch H (1988) Biphosphonates: a new class of drugs in bone disease and calcium metabolism. In: Baker PF (ed) Handbook of experimental pharmacology, vol. 83. Springer, Berlin\/Heidelberg, p 441"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1530\/acta.0.1010408","volume":"101","author":"C Rudberg","year":"1982","unstructured":"Rudberg C, Akerstr\u00f6m G, Ljunghall S, Grimelius L, Johansson H, Pertoft H, Wide L (1982) Regulation of parathyroid hormone release in primary and secondary hyperparathyroidism-studies in vivo and in vitro. Acta Endocrinol (Kopn) 101:408?413","journal-title":"Acta Endocrinol (Kopn)"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/jcem-46-2-267","volume":"46","author":"EM Brown","year":"1978","unstructured":"Brown EM, Brennan MF, Hurwitz S, Windeck R, Marx SJ, Spiegel AM, Koehler JO, Gardner G, Aurbach GD (1978) Dispersed cells prepared from human parathyroid glands: distinct calcium sensitivity of adenomas vs. primary hyperplasia. J Clin Endocrinol Metab 46:267?275","journal-title":"J Clin Endocrinol Metab"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0002-9343(79)90446-7","volume":"66","author":"EM Brown","year":"1979","unstructured":"Brown EM, Gardner DG, Brennan MF, Marx SJ, Spiegel AM, Attie MF, Downs RW, Doppmann JL, Aurbach GD (1979) Calcium-regulated parathyroid hormone release in primary hyperparathyroidism. Am J Med 66:923?931","journal-title":"Am J Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1210\/jcem-62-5-950","volume":"62","author":"E Orwoll","year":"1986","unstructured":"Orwoll E, Kane-Johnson N, Cook J, Roberts L, Strasik L, McClung M (1986) Acute parathyroid hormone secretory dynamics: hormone secretion from normal primate and adenomatous human tissue in response to changes in extracellular calcium concentrations. J Clin Endocrinol Metab 62:950?955","journal-title":"J Clin Endocrinol Metab"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2007-1003264","volume":"24","author":"E Ishimura","year":"1991","unstructured":"Ishimura E, Miki T, Harada K, Hiratani K, Nakatsuka K, Nishizawa Y, Morii H (1991) Regulation of parathyroid hormone secretion by calcium in patients with parathyroid adenoma. Horm Metab Res 24:92?94","journal-title":"Horm Metab Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1210\/edrv-12-3-291","volume":"12","author":"SL Pocotte","year":"1991","unstructured":"Pocotte SL, Ehrenstein G, Fitzpatrick LA (1991) Regulation of parathyroid hormone secretion. Endocrinol Rev 12:291?301","journal-title":"Endocrinol Rev"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02411261","volume":"34","author":"FJM Breukelen Van","year":"1982","unstructured":"Van Breukelen FJM, Bijvoet OLM, Van Oosterom AT (1982) Efficacy of aminchydroxy biphosphonate in hypercalcaemia: observation on regulation of serum calcium. Calcif Tissue Int 34:321?327","journal-title":"Calcif Tissue Int"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0002-9343(73)90090-9","volume":"54","author":"RL Dawkins","year":"1973","unstructured":"Dawkins RL, Tashijan AH, Castleman B, Moore EW (1973) Hyperparathyroidism due to clear cell hyperplasia. Am J Med 54:119?126","journal-title":"Am J Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02115782","volume":"69","author":"P Pietschmann","year":"1991","unstructured":"Pietschmann P, Niederle B, Anvari A, Woloszczuk W (1991) Serum osteocalcin levels in primary hyperparathyroidism. Klin Wochenschr 69:351?353","journal-title":"Klin Wochenschr"},{"key":"CR24","first-page":"62","volume-title":"The management of bone metastases and hypercalcaemia by osteoclast inhibition","author":"DJ Dodwell","year":"1990","unstructured":"Dodwell DJ, Howell A, Morton A, Daley-Yates PT, Hoggarth CR (1990) Pamidronate (APD) treatment of skeletal metastases from breast cancer. In: Rubens RD (ed) The management of bone metastases and hypercalcaemia by osteoclast inhibition. Hogrefe and Huber, Toronto\/Lewiston NY\/Bern\/G\u00f6ttingen\/Stuttgart, pp 62?75"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-95-1-23","volume":"95","author":"E Shane","year":"1981","unstructured":"Shane E, Bacquiran CD, Bilezikian JP (1981) Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism. Ann Intern Med 95:23?27","journal-title":"Ann Intern Med"},{"key":"CR26","first-page":"201","volume":"14","author":"S Minisola","year":"1988","unstructured":"Minisola S, Scarnecchia L, Scarda A, Bigi F, Tabolli S, Valtorta C, Mazzuoli G (1988) Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery. Miner Electrol Metab 14:201?207","journal-title":"Miner Electrol Metab"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2265.1990.tb00869.x","volume":"32","author":"RS Schmidli","year":"1990","unstructured":"Schmidli RS, Wilson I, Espiner EA, Richards AM, Donald RA (1990) Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: effect on clinical status. Clin Endocrinol 32:293?300","journal-title":"Clin Endocrinol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00296674","volume":"51","author":"SJ Gallacher","year":"1992","unstructured":"Gallacher SJ, Fraser WD, Logue FC, Dryburgh FJ, Cowan RA, Boyle IT, Ralston SH (1992) Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy. Calcif Tissue Int 51:419?423","journal-title":"Calcif Tissue Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01351832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01351832\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01351832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T10:55:47Z","timestamp":1735469747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01351832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1993,11]]}},"alternative-id":["BF01351832"],"URL":"https:\/\/doi.org\/10.1007\/bf01351832","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"type":"print","value":"0171-967X"},{"type":"electronic","value":"1432-0827"}],"subject":[],"published":{"date-parts":[[1993,11]]}}}